Summary
Johnson & Johnson (JNJ) filed an 8-K on April 16, 2019, reporting its first-quarter 2019 financial results. The report primarily consists of a press release and supplementary financial data detailing sales and earnings for the period ending March 31, 2019. Investors should note that this filing serves as the official release of these key financial metrics, offering insights into the company's performance at the start of the fiscal year. While the 8-K itself is a procedural filing, the attached press release contains the substance of the company's operational and financial condition for the quarter.
Key Highlights
- 1JNJ announced its first-quarter 2019 sales and earnings on April 16, 2019.
- 2The filing includes a press release dated April 16, 2019, detailing the Q1 2019 results.
- 3The report contains unaudited comparative supplementary sales data and condensed consolidated statements of earnings.
- 4This 8-K serves as the official disclosure of JNJ's financial performance for the quarter ended March 31, 2019.
- 5Investors can find detailed financial performance information within the attached exhibits.